Bio-Techne Corp (TECH)
NASDAQ · Healthcare · Biotechnology
Bio-Techne Corp is a Healthcare company with a market capitalization of $11.06B, a trailing P/E ratio of 101.4, and a dividend yield of 0.45%.
5-Year Price History
Latest Annual Financials · FY ending June 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q3 2026 | May 6, 2026 | $0.53 | $0.53 | +0.0% |
| Q2 2025 | February 4, 2026 | $0.46 | $0.43 | +7.0% |
| Q1 2025 | November 5, 2025 | $0.24 | $0.25 | -4.0% |
| Q4 2025 | August 6, 2025 | $0.53 | $0.50 | +6.0% |
| Q3 2025 | May 7, 2025 | $0.56 | $0.51 | +9.8% |
| Q2 2024 | February 5, 2025 | $0.42 | $0.39 | +7.7% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Bio-Techne Corp's market cap?
As of June 29, 2026, Bio-Techne Corp (TECH) has a market capitalization of $11.06B.
What is Bio-Techne Corp's P/E ratio?
Bio-Techne Corp trades at a trailing price-to-earnings (P/E) ratio of 101.4. Its forward P/E is 34.8.
Does Bio-Techne Corp pay a dividend?
Yes — Bio-Techne Corp pays a dividend yielding 0.45%, an annual payout of $0.32 per share.
What sector is TECH in?
Bio-Techne Corp is in the Healthcare sector, specifically the Biotechnology industry.
What was Bio-Techne Corp's revenue?
In its latest reported fiscal year (ending June 30, 2025), Bio-Techne Corp reported revenue of $1.22B and net income of $73.40M.
Ask your own questions about TECH
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.